Old Mission Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Old Mission Capital's VRTX Position: Q2 2022 in Review
Old Mission Capital sold out of Vertex Pharmaceuticals (VRTX) in Q2 2022, closing a stake of 18,360 shares — an estimated $4.79M sold.
Old Mission Capital first reported a position in VRTX in Q4 2017 and held it in 2 quarters. The position peaked at $4.79M in Q1 2022. 1,106 funds tracked by Wall St. Rank hold VRTX as of Q2 2022.
- Old Mission Capital reported no remaining Vertex Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
- Old Mission Capital sold 18,360 Vertex Pharmaceuticals shares in Q2 2022, an estimated $4.79M.
- Old Mission Capital first reported a position in Vertex Pharmaceuticals in Q4 2017 and held it in 2 quarters.
- Old Mission Capital's Vertex Pharmaceuticals position peaked at $4.79M in Q1 2022.
- 1,106 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2022.
Based on Old Mission Capital's 13F filing for Q2 2022, filed 5 Aug 2022.